Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02954874
Brief Title: Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

First Submitted : November 3, 2016
First Submitted that Met QC Criteria : November 3, 2016
First Posted : November 4, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : April 17, 2021
Last Update Posted : April 20, 2021 (Estimate)